Hartter N, Däumichen M, Schmidt C, Wolff M, Gründer G, Jungaberle H. [Acceptance of psilocybin-assisted therapy in German-speaking countries]. Nervenarzt. 2025 96(6):582-589. Epub 2025 Feb 12.
Wolff M, Rutrecht H, Gründer G, Jungaberle A, Jungaberle H. Key competencies for psychedelic treatment in real-world mental health care settings. Gen Hosp Psychiatry. 2025 97:11-24. Epub 2025 Sep 16.
Wolff M, Rutrecht H, Mertens L, Meijer AA, Beck J, Pérez S, Gründer G, Dziobek I, Jungaberle H. Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe's general change mechanisms. Psychol Rev. 2025 132(6):1467-1492. Epub 2025 Oct 9.
Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME. A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research. Psychedelic Med (New Rochelle). 2025 3(1):1-18.